Hyperfine Inc. (HYPR)

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced that it has commenced an underwritten public offering of its Class A common stock or, in...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine Swoop® system, via partner UpCare, earns national referencing from UniHA, France's top hospital purchasing cooperative.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches a subscription-based platform designed to empower researchers and developers advancing access and innovation in portable MRI.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...

Hyperfine (HYPR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Co...

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.14 per share a year ago.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine hits 100-patient milestone in portable MRI study, accelerating access to brain imaging in neurology clinics with next-gen Swoop® system.